Jonathan C. Javitt, Chief Scientist at NRX Pharmaceuticals, Inc. (NRXP), bought 200,000 shares at $0.58 ($116K) on 2022-06-01, disclosed to the SEC on 2022-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.58 | 100,000 | $58K | 50.0% |
| 2 | $0.58 | 100,000 | $58K | 50.0% |
| Total | $0.58 avg | 200,000 | $116K | 100% |
| Filing → |
| NRXP | BUY | 2023-08-23 | $64K | — | Filing → |
| NRXP | SELL | 2022-12-09 | $400K | — | Filing → |
| NRXP | BUY | 2022-06-02 | $5.8M | — | Filing → |